Our veterinary medical operations have good commercial opportunities in line with our human medical operations, where sales and clinical successes can be carried out in parallel. Within Vetiqure, there will be a major focus on sales in Europe, the USA and the Middle East. In parallel with the sales effort, Vetiqure will conduct clinical studies to demonstrate the competitive advantages of TSE™ compared to the older ECT (Electrochemotherapy) technology. Unlike human medicine, these studies will be smaller and associated with fewer regulatory and administrative processes.